{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:43:57Z","timestamp":1791081837169,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1007\/bf03018424","type":"journal-article","created":{"date-parts":[[2009,5,3]],"date-time":"2009-05-03T19:54:31Z","timestamp":1241380471000},"page":"672-679","source":"Crossref","is-referenced-by-count":17,"title":["Recombinant activated factor VII decreases bleeding without increasing arterial thrombosis in rabbits","Le facteur VII recombinant active diminue le saignement sans augmenter la thrombose art\u00e9rielle chez le lapin"],"prefix":"10.1007","volume":"51","author":[{"given":"Maurizio","family":"Fattorutto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Tourreau-Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Mazoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bonnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Rapha\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Cupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles-Marc","family":"Samama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03018424_CR1","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1055\/s-0038-1665434","volume":"78","author":"CR Hay","year":"1997","unstructured":"Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997; 78: 1463\u20137.","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"BF03018424_CR2","first-page":"159","volume":"26","author":"J Kristensen","year":"1996","unstructured":"Kristensen J, Killander A, Hippe E, et al. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996; 26(Suppl 1): 159\u201364.","journal-title":"Haemostasis"},{"key":"BF03018424_CR3","first-page":"431","volume":"51","author":"U Martinowitz","year":"2001","unstructured":"Martinowitz U, Kenet G, Segal E, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001; 51: 431\u20139.","journal-title":"J Trauma"},{"key":"BF03018424_CR4","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/00000542-200206000-00004","volume":"96","author":"RB Weiskopf","year":"2002","unstructured":"Weiskopf RB. Intraoperative use of recombinant activated coagulation factor VII. Anesthesiology 2002; 96: 1287\u20139.","journal-title":"Anesthesiology"},{"key":"BF03018424_CR5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archsurg.134.9.964","volume":"134","author":"ME Gnat","year":"1999","unstructured":"Gnat ME, Wallace WC, Nastanski F, et al. Improved survival following massive transfusion in patients who have undergone trauma. Arch Surg 1999; 134: 964\u201370.","journal-title":"Arch Surg"},{"key":"BF03018424_CR6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1423-0410.1998.tb05449.x","volume":"74","author":"S Hiippala","year":"1998","unstructured":"Hiippala S. Replacement of massive blood loss. Vox Sang 1998; 74: 399\u2013407.","journal-title":"Vox Sang"},{"key":"BF03018424_CR7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0037-1614059","volume":"84","author":"LM Aledort","year":"2000","unstructured":"Aledort LM. rFVTIa-its thrombogenicity (Letter). Thromb Haemost 2000; 84: 522\u20133.","journal-title":"Thromb Haemost"},{"key":"BF03018424_CR8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.CIR.54.3.365","volume":"54","author":"JD Folts","year":"1976","unstructured":"Folts JD, Crowell EB Jr, Rowe GG. Platelet aggregation in partially obstructed vessels and its elimitation with aspirin. Circulation 1976; 54: 365\u201370.","journal-title":"Circulation"},{"key":"BF03018424_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0735-1097(91)90702-B","volume":"17","author":"EJ Eichhorn","year":"1991","unstructured":"Eichhorn EJ, Grayburn PA, Willard JE, et al. Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina. J Am Coll Cardiol 1991; 17: 43\u201352.","journal-title":"J Am Coll Cardiol"},{"key":"BF03018424_CR10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood.V68.3.783.783","volume":"68","author":"BS Coller","year":"1986","unstructured":"Coller BS, Folts JD, Scudder LE, Smith SR. Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb\/IIIa receptor in an experimental animal model. Blood 1986; 68: 783\u20136.","journal-title":"Blood"},{"key":"BF03018424_CR11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1055\/s-0038-1646307","volume":"68","author":"CM Samama","year":"1992","unstructured":"Samama CM, Bonnin P, Bonneau M, et al. Comparative arterial antithrombotic activity of clopidogrel and acetylsalicylic acid in the pig. Thromb Haemost 1992; 68: 500\u20135.","journal-title":"Thromb Haemost"},{"key":"BF03018424_CR12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.RES.82.1.39","volume":"82","author":"P Golino","year":"1998","unstructured":"Golino P, Ragni M, Cirillo P, et al. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis. Circ Res 1998; 82: 39\u201346.","journal-title":"Circ Res"},{"issue":"Suppl 1","key":"BF03018424_CR13","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1097\/00001721-200004001-00028","volume":"11","author":"P Golino","year":"2000","unstructured":"Golino P, Ragni M, Cirillo P, et al. Effects of recombinant active site-blocked activated factor VII in rabbit models of carotid stenosis and myocardial infarction. Blood Coagul Fibrinolysis 2000; 11(Suppl 1): S149\u201358.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"BF03018424_CR14","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/00000542-199805000-00023","volume":"88","author":"S Delaporte-Cerceau","year":"1998","unstructured":"Delaporte-Cerceau S, Samama CM, Riou B, Bonnin P, Guillosson JJ, Coriat P. Ketorolac and enoxaparin affect arterial thrombosis and bleeding in the rabbit. Anesthesiology 1998; 88: 1310\u20137.","journal-title":"Anesthesiology"},{"key":"BF03018424_CR15","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/00000542-199905000-00031","volume":"90","author":"B Ouaknine-Orlando","year":"1999","unstructured":"Ouaknine-Orlando B, Samama CM, Riou B, et al. Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology 1999; 90: 1454\u201361.","journal-title":"Anesthesiology"},{"key":"BF03018424_CR16","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1055\/s-0038-1657671","volume":"78","author":"J Treib","year":"1997","unstructured":"Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 1997; 78: 974\u201383.","journal-title":"Thromb Haemost"},{"key":"BF03018424_CR17","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1213\/00000539-199376060-00002","volume":"76","author":"J Boldt","year":"1993","unstructured":"Boldt J, Knothe C, Zickmann B, Andres P, Dapper F, Hempelmann G. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 1993; 76: 1185\u201390.","journal-title":"Anesth Analg"},{"key":"BF03018424_CR18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1213\/00000539-199608000-00011","volume":"83","author":"NH Vogt","year":"1996","unstructured":"Vogt NH, Bothner U, Lerch G, Lindner KH, Georgieff M. Large-dose administration of 6% hydroxyethyl starch 200\/0.5 for total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesth Analg 1996; 83: 262\u20138.","journal-title":"Anesth Analg"},{"key":"BF03018424_CR19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0049-3848(90)90116-T","volume":"59","author":"V Diness","year":"1990","unstructured":"Diness V, Lund-Hansen T, Hedner U. Effect of recombinant human FVIIa on warfarin-induced bleeding in rats. Thromb Res 1990; 59: 921\u20139.","journal-title":"Thromb Res"},{"key":"BF03018424_CR20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0049-3848(00)00397-2","volume":"101","author":"M Elg","year":"2001","unstructured":"Elg M, Carlsson S, Gustafsson D. Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor. Thromb Res 2001; 101: 145\u201357.","journal-title":"Thromb Res"},{"key":"BF03018424_CR21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9343(99)00398-8","volume":"108","author":"AJ Vlot","year":"2000","unstructured":"Vlot AJ, Ton E, Mackaay AJ, Kramer MH, Gaillard CA. Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII. Am J Med 2000; 108: 421\u20132.","journal-title":"Am J Med"},{"key":"BF03018424_CR22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2000-8455","volume":"26","author":"DM Monroe","year":"2000","unstructured":"Monroe DM, Hoffman M, Allen GA, Roberts HR. The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia. Semin Thromb Hemost 2000; 26: 373\u20137.","journal-title":"Semin Thromb Hemost"},{"key":"BF03018424_CR23","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(88)90259-0","volume":"2","author":"U Hedner","year":"1988","unstructured":"Hedner U, Glazer S, Pingel K, et al. Succesful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy (Letter). Lancet 1988; 2: 1193.","journal-title":"Lancet"},{"issue":"Suppl 12","key":"BF03018424_CR24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0037-1963(01)90148-9","volume":"38","author":"HR Roberts","year":"2001","unstructured":"Roberts HR. Recombinant factor VIIa (Novoseven\u00ae) and the safety of treatment. Semin Hematol 2001; 38(Suppl 12): 48\u201350.","journal-title":"Semin Hematol"},{"issue":"Suppl 1","key":"BF03018424_CR25","first-page":"S147","volume":"9","author":"U Hedner","year":"1998","unstructured":"Hedner U. Recombinant activated factor VII as a universal haemostatic agent. Blood Coagul Fibrinolysis 1998; 9(Suppl 1): S147\u201352.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"BF03018424_CR26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0049-3848(00)00398-4","volume":"101","author":"M Elg","year":"2001","unstructured":"Elg M, Carhson S, Gustafsson D. Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits. Thromb Res 2001; 101: 159\u201370.","journal-title":"Thromb Res"},{"key":"BF03018424_CR27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","volume":"99","author":"DM Monroe","year":"1997","unstructured":"Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997; 99: 542\u20137.","journal-title":"Br J Haematol"},{"key":"BF03018424_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00001721-199008000-00009","volume":"1","author":"U Hedner","year":"1990","unstructured":"Hedner U, Ljundberg J, Lund-Hansen T. Comparison of the effect of plasma-derived recombinant human FVIIa in vitro and in a rabbit model. Blood Coagul Fibrinolysis 1990; 1: 145\u201351.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"BF03018424_CR29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0049-3848(92)90142-W","volume":"67","author":"V Diness","year":"1992","unstructured":"Diness V, Bregengaard C, Erhardtsen E, Hedner U. Recombinant human factor VIIa (rRFVIIa) in a rabbit stasis model. Thromb Res 1992; 67: 233\u201341.","journal-title":"Thromb Res"},{"key":"BF03018424_CR30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00001721-199308000-00001","volume":"4","author":"BG Macik","year":"1993","unstructured":"Macik BG, Lindley CM, Lusher J, et al. Safety and initial clinical efficacy of the dose levels of recombinant activated factor VII (rFVTIa): results of a phase I study. Blood Coagul Fibrinolysis 1993; 4: 521\u20137.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl 3","key":"BF03018424_CR31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2516.1999.00032.x","volume":"5","author":"D Green","year":"1999","unstructured":"Green D. Complications associated with the treatment of haemophiliacs with inhibitors. Haemophilia 1999; 5(Suppl 3): 11\u20137.","journal-title":"Haemophilia"},{"key":"BF03018424_CR32","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1055\/s-0037-1614918","volume":"82","author":"K Peerlinck","year":"1999","unstructured":"Peerlinck K, Vermeylen J. Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitor. Thromb Haemost 1999; 82: 1775\u20136.","journal-title":"Thromb Haemost"},{"key":"BF03018424_CR33","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1213\/01.ANE.0000099366.73625.DD","volume":"98","author":"E Marret","year":"2004","unstructured":"Marret E, Bonnin P, Mazoyer E, et al. Effects of a polymerized bovine-derived hemoglobin solution in a rabbit model of arterial thrombosis and bleeding. Anesth Analg 2004; 98: 604\u201310.","journal-title":"Anesth Analg"},{"key":"BF03018424_CR34","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1001\/jama.1994.03510460072036","volume":"271","author":"TF Lmperiale","year":"1994","unstructured":"Lmperiale TF, Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994; 271: 1780\u20135.","journal-title":"JAMA"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03018424.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03018424\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03018424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T21:57:35Z","timestamp":1589752655000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03018424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["BF03018424"],"URL":"https:\/\/doi.org\/10.1007\/bf03018424","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}